CFB
ABBV icon

Cullen/Frost Bankers’s AbbVie ABBV Stock Holding History

Cullen/Frost Bankers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86M Sell
341,851
-16,477
-5% -$3.54M 0.85% 26
2026
Q1 		$77.9M Sell
358,328
-7,197
-2% -$1.6M 0.89% 29
2025
Q4 		$83.5M Sell
365,525
-16,653
-4% -$3.79M 0.92% 26
2025
Q3 		$88.5M Sell
382,178
-14,047
-4% -$2.86M 1.03% 23
2025
Q2 		$73.5M Buy
396,225
+11,730
+3% +$2.18M 0.92% 27
2025
Q1 		$80.6M Buy
384,495
+3,573
+0.9% +$695K 1.13% 24
2024
Q4 		$67.7M Sell
380,922
-21,182
-5% -$3.89M 0.93% 26
2024
Q3 		$79.4M Buy
402,104
+4,293
+1% +$801K 1.08% 26
2024
Q2 		$68.2M Buy
397,811
+30,259
+8% +$5.01M 0.99% 26
2024
Q1 		$66.9M Buy
367,552
+7,848
+2% +$1.35M 0.99% 26
2023
Q4 		$55.7M Buy
359,704
+35,053
+11% +$5.11M 0.88% 28
2023
Q3 		$48.4M Buy
324,651
+2,166
+0.7% +$318K 0.84% 30
2023
Q2 		$43.4M Sell
322,485
-4,308
-1% -$632K 0.74% 32
2023
Q1 		$52.1M Buy
326,793
+11,657
+4% +$1.78M 0.95% 23
2022
Q4 		$50.9M Buy
315,136
+25,579
+9% +$3.92M 0.97% 24
2022
Q3 		$38.9M Buy
289,557
+46,747
+19% +$6.71M 0.89% 27
2022
Q2 		$37.2M Sell
242,810
-202
-0.1% -$30.9K 0.83% 27
2022
Q1 		$39.4M Buy
243,012
+3,420
+1% +$497K 0.77% 30
2021
Q4 		$32.4M Sell
239,592
-7,337
-3% -$867K 0.62% 42
2021
Q3 		$26.6M Sell
246,929
-2,894
-1% -$331K 0.54% 48
2021
Q2 		$28.1M Sell
249,823
-1,152
-0.5% -$130K 0.57% 48
2021
Q1 		$27.2M Sell
250,975
-4,777
-2% -$511K 0.6% 47
2020
Q4 		$27.4M Sell
255,752
-41,143
-14% -$3.95M 0.63% 40
2020
Q3 		$26M Sell
296,895
-190,151
-39% -$17.9M 0.65% 39
2020
Q2 		$47.8M Buy
487,046
+36,771
+8% +$3.24M 1.26% 15
2020
Q1 		$34.3M Buy
450,275
+3,835
+0.9% +$327K 1.19% 16
2019
Q4 		$39.5M Buy
446,440
+15,194
+4% +$1.26M 1.08% 18
2019
Q3 		$32.7M Buy
431,246
+19,410
+5% +$1.33M 0.97% 24
2019
Q2 		$29.9M Sell
411,836
-1,627
-0.4% -$128K 0.93% 23
2019
Q1 		$33.2M Buy
413,463
+54,022
+15% +$4.42M 1.02% 22
2018
Q4 		$33.1M Sell
359,441
-54,704
-13% -$4.81M 1.23% 13
2018
Q3 		$39.2M Sell
414,145
-49,456
-11% -$4.69M 1.22% 12
2018
Q2 		$43M Buy
463,601
+10,389
+2% +$1.01M 1.33% 12
2018
Q1 		$42.9M Buy
453,212
+25,396
+6% +$2.79M 1.26% 12
2017
Q4 		$41.4M Buy
427,816
+3,885
+0.9% +$366K 1.31% 11
2017
Q3 		$37.7M Sell
423,931
-15,414
-4% -$1.17M 1.23% 11
2017
Q2 		$31.9M Sell
439,345
-9,817
-2% -$660K 1.07% 18
2017
Q1 		$29.3M Sell
449,162
-41,935
-9% -$2.64M 1% 20
2016
Q4 		$30.8M Buy
491,097
+9,151
+2% +$559K 1.06% 16
2016
Q3 		$30.4M Sell
481,946
-8,290
-2% -$537K 1.09% 16
2016
Q2 		$30.4M Sell
490,236
-2,200
-0.4% -$134K 1.13% 15
2016
Q1 		$28.1M Buy
492,436
+12,981
+3% +$724K 1.05% 19
2015
Q4 		$28.4M Buy
479,455
+23,085
+5% +$1.33M 1.07% 19
2015
Q3 		$24.8M Buy
456,370
+4,960
+1% +$323K 0.99% 23
2015
Q2 		$30.3M Sell
451,410
-20,296
-4% -$1.33M 1.13% 11
2015
Q1 		$27.6M Buy
471,706
+56,063
+13% +$3.39M 1.03% 14
2014
Q4 		$27.2M Sell
415,643
-7,308
-2% -$461K 1.05% 14
2014
Q3 		$24.4M Buy
422,951
+59,757
+16% +$3.32M 0.99% 18
2014
Q2 		$20.5M Buy
363,194
+32,806
+10% +$1.72M 0.83% 26
2014
Q1 		$17M Buy
330,388
+782
+0.2% +$39.5K 0.73% 38
2013
Q4 		$17.4M Buy
329,606
+16,348
+5% +$803K 0.77% 38
2013
Q3 		$14M Buy
313,258
+14,037
+5% +$622K 0.69% 39
2013
Q2 		$12.4M Buy
+299,221
New +$13.1M 0.65% 41

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cullen/Frost Bankers's ABBV Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its AbbVie (ABBV) stake by 4.6% in Q2 2026, selling an estimated $3.54M and leaving 341,851 shares worth $86M. The position accounts for 0.85% of the portfolio, ranked #26.

Cullen/Frost Bankers first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $88.5M in Q3 2025. 1,989 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cullen/Frost Bankers held 341,851 shares of AbbVie worth $86M as of Q2 2026.
  • Cullen/Frost Bankers sold 16,477 AbbVie shares in Q2 2026, an estimated $3.54M.
  • AbbVie made up 0.85% of Cullen/Frost Bankers's portfolio in Q2 2026, its #26 holding.
  • Cullen/Frost Bankers first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Cullen/Frost Bankers's AbbVie position peaked at $88.5M in Q3 2025.
  • 1,989 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.